Showing results (11-20 of 200) with videos related to
Sort By:
Pageof 20
Australian and New Zealand Journal of Medicine|June 27, 2000
Sympathetic activation and the role of beta-blockers in chronic heart failureH KrumSchweizerische Medizinische Wochenschrift|March 7, 1998
[Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia]D AtarClinical and Experimental Pharmacology & Physiology|April 1, 1994
Spontaneous endothelin production by circulating mononuclear cells from patients with chronic heart failure but not from normal subjectsH Krum, S ItescuCurrent Opinion in Investigational Drugs (London, England : 2000)|September 22, 2001
Eplerenone (GD Searle & Co)J Martin, H KrumInternal Medicine Journal|December 6, 2003
New and emerging drug therapies for the management of acute heart failureH Krum, D LiewThe American Journal of Cardiology|May 12, 2001
Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factorS D Katz, H KrumAustralian Family Physician|May 15, 1998
New and emerging drug treatments for hypertensionH Krum, A M PellizzerAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Systematic review of the efficacy and safety of perhexiline in the treatment of ischemic heart diseaseS M Killalea, H KrumThe American Journal of Cardiology|February 19, 1998
Effect of endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failureH Krum, S D KatzAustralian Family Physician|July 1, 1996
ACE inhibitors in cardiovascular disease. Which patient? Which drug? Which dose?A M Pellizzer, H KrumPageof 20